Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
3SBio Unveils 2017 Annual Results: Revenue Soars by 33.5% 2018-03-26 22:09
China FDA Approves New Once-Weekly Bydureon(R) to Improve Glycemic Control in Patients with Type-2 Diabetes 2018-01-04 14:46
3SBio Accelerates Expansion of its Global Biologics Platform by Acquiring the Canadian Biomanufacturing Business of Therapure 2017-09-03 21:01
3SBio Inc. Appoints Dr. Zhenping Zhu as President of Research & Development and Chief Scientific Officer 2017-01-09 16:00
1